Disease type | lncRNA involved | Cell proliferation approach | Mechanism/Effect on cell proliferation | Gene manipulation system | References |
---|---|---|---|---|---|
AML | CASC15 | MTS assay | CASC15 expression may limit cell proliferation by regulation SOX4 expression | siRNA | [93] |
AML | CCAT1 | CKK-8 assay | Promotes cell proliferation by sequestering tumor suppressive miR155 | shRNA | [89] |
AML | MEG3 | MTT assay | Suppresses cell proliferation through inducing G0/G1 cell cycle arrest | siRNA | [91] |
AML | NEAT1 | CCK-8 assay | Modulates cell proliferation by regulating miR-23a-3p/SMC1A | pcDNA3.1-NEAT1 (overexpression of NEAT1) | [90] |
AML | TUG1 | CKK-8 assay | Increases cell proliferation through targeting AURKA | Lentiviral vector-mediated gene manipulation | [92] |
AML | UCA1 | Trypan Blue exclusion assay | Sustains cell proliferation by repressing p27kip1 expression | shRNA | [87] |
ALL | LINC-PINT | MTSÂ assay | Overexpressed linc-PINT decreases cell proliferation through apoptosis activation and cell cycle arrest at G2/M phase | Overexpression of linc-PINT by linc-PINT-pCDNA3 | [94] |
ALL | NALT | CKK-8 assay | Upexpressed NALT promotes cell proliferation through interacting with NOTCH signaling pathway | shRNA | [86] |
APL | PVT1 | CKK-8 assay | Promotes cell proliferation by MYC | siRNA | [95] |
CML | HULC | MTT assay | Promotes cell proliferation by regulating PI3K/AKT signaling pathway | shRNA | [97] |
CML | MEG3 | MTT assay | Overexpressed MEG3 inhibits cell proliferation by sponging miR-21 | pLVX-hMEG3-ZsGreen-Puro lentiviral overexpression vector | [96] |
CML | MEG3 | CCK-8 assay | Overexpressed MEG3 inhibits cell proliferation by inhibiting miR-184 | siRNA | [188] |
CML | PLIN2 | MTT assay | Overexpressed PLIN2 promotes cell proliferation through activating GSK-3β and β-catenin | shRNA | [98] |
CLL | BM742401 | MTT assay | Overexpressed BM742401 inhibits cell proliferation through caspase-9 dependent intrinsic pathway | ASO | [88] |